Advertisement
Advertisement
BIO
Bio-Rad Laboratories, Inc.Class A
292.39
USDSponsored
-2.52
-0.85%
Jan 30, 11:47 UTC -5
Open
BIO Earnings Reports
Positive Surprise Ratio
BIO beat 29 of 40 last estimates.
73%
Next Report
Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$700.89M
/$2.73
Implied change from Q3 25 (Revenue/ EPS)
+7.33%
/+21.33%
Implied change from Q4 24 (Revenue/ EPS)
+5.00%
/-5.86%
Bio-Rad Laboratories, Inc.Class A earnings per share and revenue
On Oct 29, 2025, BIO reported earnings of 2.25 USD per share (EPS) for Q3 25, beating the estimate of 1.95 USD, resulting in a 15.74% surprise. Revenue reached 653.00 million, compared to an expected 657.81 million, with a -0.73% difference. The market reacted with a -4.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of 2.73 USD, with revenue projected to reach 700.89 million USD, implying an increase of 21.33% EPS, and increase of 7.33% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
FAQ
What were Bio-Rad Laboratories, Inc.Class A's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bio-Rad Laboratories, Inc.Class A reported EPS of $2.25, beating estimates by 15.74%, and revenue of $653.00M, -0.73% below expectations.
How did the market react to Bio-Rad Laboratories, Inc.Class A's Q3 2025 earnings?
The stock price moved down -4.65%, changed from $319.47 before the earnings release to $304.61 the day after.
When is Bio-Rad Laboratories, Inc.Class A expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for Bio-Rad Laboratories, Inc.Class A's next earnings report?
Based on 6
analysts, Bio-Rad Laboratories, Inc.Class A is expected to report EPS of $2.73 and revenue of $700.89M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement